{"id":6523,"date":"2021-04-23T14:28:26","date_gmt":"2021-04-23T14:28:26","guid":{"rendered":"https:\/\/etfinveste.pt\/?page_id=6523"},"modified":"2021-04-24T15:50:12","modified_gmt":"2021-04-24T15:50:12","slug":"analise24_heal","status":"publish","type":"page","link":"https:\/\/etfinveste.pt\/analise24_heal\/","title":{"rendered":"iShares Healthcare Innovation UCITS ETF \u2013 HEAL"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

iShares Healthcare Innovation UCITS ETF – HEAL<\/span><\/strong><\/h1><\/div><\/div>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

DESCRI\u00c7\u00c3O<\/span><\/strong><\/h4>

Desta vez iremos analisar um ETF da iShares lan\u00e7ado em 2016, vocacionado na inova\u00e7\u00e3o do setor da sa\u00fade. O HEAL replica, de forma otimizada, o \u00edndice<\/span>\u00a0<\/i><\/span>STOXX Global Breakthrough Healthcare<\/i>\u00a0que abrange cerca de 130 companhias pioneiras no desenvolvimento e inova\u00e7\u00e3o na \u00e1rea da sa\u00fade, seja em pa\u00edses desenvolvidos ou emergentes. Tamb\u00e9m est\u00e3o englobadas algumas empresas tecnol\u00f3gicas, de automa\u00e7\u00e3o\/rob\u00f3tica e digitaliza\u00e7\u00e3o, com interven\u00e7\u00e3o direta neste setor. Outro aspeto interessante neste \u00edndice \u00e9 a exclus\u00e3o de empresas que n\u00e3o respeitam um conjunto de crit\u00e9rios ESG (Enviromental, Social e Governance<\/i>), por exemplo, companhias n\u00e3o complacentes ao respeito dos Direitos Humanos, envolvidas no neg\u00f3cio de armas ou na explora\u00e7\u00e3o de energias f\u00f3sseis.
De salientar o impacto das novas tecnologias neste setor nos \u00faltimos anos, ainda mais refor\u00e7ado na \u00faltima crise pand\u00e9mica, levando muitos servi\u00e7os de sa\u00fade n\u00e3o s\u00f3 a usar novas medidas para contactar os seus utentes ou rastrear redes de cont\u00e1gio , como para implementar de forma urgente, novos f\u00e1rmacos e vacinas para preven\u00e7\u00e3o da COVID-19.\u00a0Este artigo muito interessante da Forbes<\/u><\/a>, descreve um conjunto de exemplos de sucesso na simbiose entre os dois setores, sa\u00fade e tecnologia, no combate ao coronav\u00edrus.<\/h4>

De momento o HEAL \u00e9 o ETF detentor do maior AUM no setor sa\u00fade, atualmente com \u20ac 1,944 mil milh\u00f5es, bem superior ao ETF da L&G, o DOCT, que tamb\u00e9m abrange a vertente inova\u00e7\u00e3o nesta \u00e1rea. O portf\u00f3lio do HEAL \u00e9 ainda reajustado anualmente.<\/h4>

O HEAL est\u00e1 tamb\u00e9m dispon\u00edvel com comiss\u00f5es gr\u00e1tis em duas das corretoras online mais usadas na Europa, isto se os investidores cumprirem um conjunto de regras\u00a0j\u00e1 exemplificadas nestes dois artigos:\u00a0Degiro<\/a><\/u>, <\/span>XTB<\/u><\/a>.\u00a0\u00a0<\/span><\/h4>

Neste momento, a Bolsa XETRA ser\u00e1 a escolha mais recomendada aos investidores residentes em Portugal, pela possibilidade de transa\u00e7\u00e3o em euros. Na bolsa de valores alem\u00e3, este ETF tem o ticker 2B78 e n\u00e3o o mais conhecido – HEAL.<\/h4>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

DIVERSIFICA\u00c7\u00c3O<\/h4>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Como esperado, o HEAL possui maior exposi\u00e7\u00e3o ao setor da sa\u00fade, com mais de 96% de aloca\u00e7\u00e3o.\u00a0\u00a0
Avaliando o quadro de empresas, \u00e9 demonstrado que 18,05% do HEAL \u00e9 representado pelas suas 10 maiores empresas, valor razo\u00e1vel dado que \u00e9 constitu\u00eddo por cerca de 130 holdings.\u00a0
<\/span>Verifica-se uma maior exposi\u00e7\u00e3o de companhias dos EUA, onde 8 das 10 empresas t\u00eam sede nesse pa\u00eds. N\u00e3o s\u00e3o empresas muito conhecidas na sua generalidade, mas que abrangem v\u00e1rias \u00e1reas, seja no tratamento de doen\u00e7as como o cancro, com m\u00e9todos mais inovadores como a medicina gen\u00e9tica ou empresas biotecnol\u00f3gicas.<\/h4>

Analisando individualmente os resultados em Bolsa do TOP 10, \u00e9 evidenciado uma tend\u00eancia muito positiva de crescimento em praticamente todas as empresas\u00a0no curto e longo prazo<\/span>, mas principalmente ap\u00f3s mar\u00e7o de 2020. Companhias como a\u00a0<\/span>Nuance Communications\u00a0ou a\u00a0<\/span>Natera conseguiram facilmente obter crescimentos superiores a 100% em bolsa, comparativamente ao ano passado.\u00a0<\/span><\/h4>
\u00a0<\/div>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t
SETOR<\/th>PESO<\/th>\n<\/tr>\n<\/thead>\n
Sa\u00fade e Farmac\u00eauticas<\/td>96.43%<\/td>\n<\/tr>\n
Tecnologias de Informa\u00e7\u00e3o\t<\/td>3.23%<\/td>\n<\/tr>\n
Moeda e\/ou Derivados<\/td>0.35%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
EMPRESA<\/th>PESO<\/th>\n<\/tr>\n<\/thead>\n
NOVOCURE LTD<\/td>2.7%<\/td>\n<\/tr>\n
NUANCE COMMUNICATIONS INC<\/td>2.03%<\/td>\n<\/tr>\n
NATERA INC<\/td>1.82%<\/td>\n<\/tr>\n
HALOZYME THERAPEUTICS INC<\/td>1.8%<\/td>\n<\/tr>\n
GUARDANT HEALTH INC<\/td>1.8%<\/td>\n<\/tr>\n
CRISPR THERAPEUTICS AG<\/td>1.65%<\/td>\n<\/tr>\n
BEIGENE LTD<\/td>1.59%<\/td>\n<\/tr>\n
FATE THERAPEUTICS INC<\/td>1.59%<\/td>\n<\/tr>\n
BIO TECHNE CORP<\/td>1.54%<\/td>\n<\/tr>\n
PRA HEALTH SCIENCES INC<\/td>1.53%<\/td>\n<\/tr>\n
PESO EMPRESAS TOP 10\t<\/td>18.05%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

PERFORMANCE<\/h4>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Analisando o desempenho gr\u00e1fico deste ETF, destaca-se a tend\u00eancia acentuada de subida ap\u00f3s mar\u00e7o de 2020. Ap\u00f3s a uma ligeira queda nessa data, o seu NAV recuperou totalmente e superou o seu valor pr\u00e9-pandemia, batendo no passado m\u00eas de fevereiro o seu m\u00e1ximo hist\u00f3rico de \u20ac 9,33. Desde esse per\u00edodo, o HEAL teve uma ligeira reca\u00edda, estando o seu NAV a lateralizar entre os \u20ac 8,00 e \u20ac 8,60.<\/h4>

\u00a0<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Verificando os resultados acumulados do HEAL, \u00e0 exce\u00e7\u00e3o do prazo de 3 meses, apresenta resultados muito positivos em diferentes per\u00edodos.\u00a0<\/span>Desde o ano passado \u00e9 poss\u00edvel apurar um crescimento superior a 40% e no m\u00e9dio prazo os resultados acumulados sobem para perto dos 60%. Contudo \u00e9\u00a0comparativamente ao seu lan\u00e7amento, em setembro de 2016, que os resultados deste ETF surpreendem obtendo um crescimento de mais de 90% desde essa data.<\/span><\/h4>

Apesar disso, \u00e9 percet\u00edvel a queda que o HEAL obteve ap\u00f3s o seu m\u00e1ximo hist\u00f3rico, houve uma ligeira recupera\u00e7\u00e3o comparado ao \u00faltimo m\u00eas, ainda assim, \u00e9 not\u00f3rio a desacelera\u00e7\u00e3o desde o in\u00edcio de 2021.<\/h4>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t
PERFORMANCE(\u20ac)(at\u00e9 23\/04\/2021)<\/th>HEAL<\/th>\n<\/tr>\n<\/thead>\n
1 M\u00caS<\/td>3.34%<\/td>\n<\/tr>\n
3 MESES<\/td>-3.24%<\/td>\n<\/tr>\n
YTD<\/td>3.96%<\/td>\n<\/tr>\n
1 ANO<\/td>42.67%<\/td>\n<\/tr>\n
3 ANOS<\/td>58.61%<\/td>\n<\/tr>\n
Desde Lan\u00e7amento<\/td>91.6%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

OUTROS DADOS<\/h4>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

O HEAL possui um TER de 0,40% ficando em ligeira vantagem face ao ETF da L&G, o j\u00e1 referenciado DOCT, que regista 0,49%<\/span>.
Quanto \u00e0 diversifica\u00e7\u00e3o geogr\u00e1fica, existe uma maior exposi\u00e7\u00e3o nos EUA em mais de 66% a\u00ed alocados, registando uma grande diferen\u00e7a face ao restantes pa\u00edses da lista.<\/h4>

Verificando alternativas nos EUA, n\u00e3o aparenta existir nenhum outro que siga o \u00edndice\u00a0STOXX Global Breakthrough Healthcare<\/i>,<\/i> talvez o mais similar seja o IXJ, tamb\u00e9m da iShares, mas \u00e9 mais focado nas empresas farmac\u00eauticas.
<\/span>Finalmente, o HEAL n\u00e3o possui qualquer distribui\u00e7\u00e3o\u00a0de dividendos.<\/i><\/span><\/h4>

\u00a0<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
PA\u00cdS<\/th>PESO<\/th>\n<\/tr>\n<\/thead>\n
United States<\/td>66.39%<\/td>\n<\/tr>\n
Japan<\/td>5.23%<\/td>\n<\/tr>\n
Korea (South)<\/td>5.01%<\/td>\n<\/tr>\n
China<\/td>3.85%<\/td>\n<\/tr>\n
Germany<\/td>3.50%<\/td>\n<\/tr>\n
Switzerland<\/td>2.94%<\/td>\n<\/tr>\n
Belgium<\/td>2.40%<\/td>\n<\/tr>\n
Sweden<\/td>2.17%<\/td>\n<\/tr>\n
India<\/td>2.12%<\/td>\n<\/tr>\n
France<\/td>1.78%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
C\u00f3digo ISIN\u00a0<\/td>IE00BYZK4776<\/td>\n<\/tr>\n
Ticker<\/td>HEAL \/ 2B78<\/td>\n<\/tr>\n
Sociedade gestora<\/td>iShares<\/td>\n<\/tr>\n
Data de lan\u00e7amento<\/td>08\/09\/2016<\/td>\n<\/tr>\n
Moeda<\/td>USD<\/td>\n<\/tr>\n
Categoria<\/td>A\u00e7\u00f5es<\/td>\n<\/tr>\n
NAV<\/td>\u20ac8.60<\/td>\n<\/tr>\n
AUM<\/td>\u20ac1,94mM<\/td>\n<\/tr>\n
Distribui\u00e7\u00e3o de Dividendos<\/td>N\u00e3o - Acumulativo<\/td>\n<\/tr>\n
Total Expense Ratio (TER)\u00a0<\/td>0.40%<\/td>\n<\/tr>\n
Beta (5 anos)<\/td>1.12<\/td>\n<\/tr>\n
R\u00e9plica ETF USA<\/td>IXJ<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Aprecia\u00e7\u00e3o<\/h3>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
 \"\u2705\" O Potencial da Inova\u00e7\u00e3o no setor Sa\u00fade + ESG<\/span><\/h6>\n
– A simbiose entre os setores da sa\u00fade e tecnologia, tem apresentado excelentes resultados, vis\u00edveis por exemplo, nesta altura pand\u00e9mica. \u00c9 muito interessante acompanhar o desenvolvimento de novas formas de preven\u00e7\u00e3o ou cura em doen\u00e7as consideradas graves, como o cancro, ao conhecer a lista de empresas que constituem o HEAL. Saliento tamb\u00e9m a import\u00e2ncia na adi\u00e7\u00e3o de crit\u00e9rios ESG ao selecionar as companhias integrantes neste ETF. Pessoalmente acho muito positivo investir em empresas que podem fazer a diferen\u00e7a e aumentar a qualidade de vida da popula\u00e7\u00e3o em geral;<\/h6>\n

\"\u2705\" Performance<\/span><\/h4>\n
– Apesar do HEAL apresentar uma desacelera\u00e7\u00e3o desde o in\u00edcio de 2021, a sua performance global \u00e9 positiva. Comparativamente ao seu lan\u00e7amento, cresceu cerca de 90% e desde o ano passado regista mais de 40% em resultados acumulados;<\/h6>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

\"\ud83d\udfe5\"\u00a0Diversifica\u00e7\u00e3o<\/span><\/h4>
– Pelo facto de estar apenas alocado em um setor – sa\u00fade – o n\u00edvel de risco torna-se maior. Tamb\u00e9m a elevada aloca\u00e7\u00e3o de mais de 66% em empresas com sede nos EUA, limita a diversifica\u00e7\u00e3o geogr\u00e1fica, pois a performance deste ETF pode depender muito do desempenho econ\u00f3mico desse pa\u00eds. Ainda assim \u00e9 positivo a diversifica\u00e7\u00e3o e n\u00famero de holdings, apenas 18,05% do HEAL \u00e9 composto pelo seu Top 10, constitu\u00eddo na totalidade por mais de 130 empresas;<\/span><\/h6>

\"\ud83d\udfe5\"\u00a0Expectativas Futuras<\/span><\/h4>
– Como referido, o HEAL bateu recentemente o seu m\u00e1ximo hist\u00f3rico, registando os \u20ac 9,33, mas evidencia uma queda ap\u00f3s esse registo. Ficam algumas d\u00favidas sobre o desempenho futuro deste ETF, que poder\u00e1 ter sido muito alavancado dado a situa\u00e7\u00e3o pand\u00e9mica no \u00faltimo ano;<\/span><\/h6>

\u00a0<\/h4>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

IE00BYZK4776 2B78 DRDR<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

iShares Healthcare Innovation UCITS ETF – HEAL DESCRI\u00c7\u00c3O Desta vez iremos analisar um ETF da iShares lan\u00e7ado em 2016, vocacionado na inova\u00e7\u00e3o do setor da sa\u00fade. O HEAL replica, de forma otimizada, o \u00edndice STOXX Global Breakthrough Healthcare que abrange cerca de 130 companhias pioneiras no desenvolvimento e inova\u00e7\u00e3o na \u00e1rea da sa\u00fade, seja em pa\u00edses desenvolvidos …<\/p>\n

iShares Healthcare Innovation UCITS ETF \u2013 HEAL<\/span> Read More »<\/a><\/p>\n","protected":false},"author":1,"featured_media":6555,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6523","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\niShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/etfinveste.pt\/analise24_heal\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste\" \/>\n<meta property=\"og:description\" content=\"iShares Healthcare Innovation UCITS ETF – HEAL DESCRI\u00c7\u00c3O Desta vez iremos analisar um ETF da iShares lan\u00e7ado em 2016, vocacionado na inova\u00e7\u00e3o do setor da sa\u00fade. O HEAL replica, de forma otimizada, o \u00edndice STOXX Global Breakthrough Healthcare que abrange cerca de 130 companhias pioneiras no desenvolvimento e inova\u00e7\u00e3o na \u00e1rea da sa\u00fade, seja em pa\u00edses desenvolvidos … iShares Healthcare Innovation UCITS ETF \u2013 HEAL Read More »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/etfinveste.pt\/analise24_heal\/\" \/>\n<meta property=\"og:site_name\" content=\"ETFinveste\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ETFinveste\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-24T15:50:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"217\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ETFinveste\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/\",\"url\":\"https:\/\/etfinveste.pt\/analise24_heal\/\",\"name\":\"iShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste\",\"isPartOf\":{\"@id\":\"https:\/\/etfinveste.pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png\",\"datePublished\":\"2021-04-23T14:28:26+00:00\",\"dateModified\":\"2021-04-24T15:50:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/etfinveste.pt\/analise24_heal\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage\",\"url\":\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png\",\"contentUrl\":\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png\",\"width\":249,\"height\":217},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/etfinveste.pt\/analise24_heal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/etfinveste.pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iShares Healthcare Innovation UCITS ETF \u2013 HEAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/etfinveste.pt\/#website\",\"url\":\"https:\/\/etfinveste.pt\/\",\"name\":\"ETFinveste\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/etfinveste.pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/etfinveste.pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/etfinveste.pt\/#organization\",\"name\":\"ETFinveste\",\"url\":\"https:\/\/etfinveste.pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/etfinveste.pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/02\/5b783120-b4fb-4def-8cb6-5eabeb8a8f6a_200x200.png\",\"contentUrl\":\"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/02\/5b783120-b4fb-4def-8cb6-5eabeb8a8f6a_200x200.png\",\"width\":200,\"height\":200,\"caption\":\"ETFinveste\"},\"image\":{\"@id\":\"https:\/\/etfinveste.pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ETFinveste\",\"https:\/\/x.com\/ETFinveste\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/etfinveste.pt\/analise24_heal\/","og_locale":"en_US","og_type":"article","og_title":"iShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste","og_description":"iShares Healthcare Innovation UCITS ETF – HEAL DESCRI\u00c7\u00c3O Desta vez iremos analisar um ETF da iShares lan\u00e7ado em 2016, vocacionado na inova\u00e7\u00e3o do setor da sa\u00fade. O HEAL replica, de forma otimizada, o \u00edndice STOXX Global Breakthrough Healthcare que abrange cerca de 130 companhias pioneiras no desenvolvimento e inova\u00e7\u00e3o na \u00e1rea da sa\u00fade, seja em pa\u00edses desenvolvidos … iShares Healthcare Innovation UCITS ETF \u2013 HEAL Read More »","og_url":"https:\/\/etfinveste.pt\/analise24_heal\/","og_site_name":"ETFinveste","article_publisher":"https:\/\/www.facebook.com\/ETFinveste","article_modified_time":"2021-04-24T15:50:12+00:00","og_image":[{"width":249,"height":217,"url":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ETFinveste","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/etfinveste.pt\/analise24_heal\/","url":"https:\/\/etfinveste.pt\/analise24_heal\/","name":"iShares Healthcare Innovation UCITS ETF \u2013 HEAL - ETFinveste","isPartOf":{"@id":"https:\/\/etfinveste.pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage"},"image":{"@id":"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage"},"thumbnailUrl":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png","datePublished":"2021-04-23T14:28:26+00:00","dateModified":"2021-04-24T15:50:12+00:00","breadcrumb":{"@id":"https:\/\/etfinveste.pt\/analise24_heal\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/etfinveste.pt\/analise24_heal\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/etfinveste.pt\/analise24_heal\/#primaryimage","url":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png","contentUrl":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/04\/heal-1.png","width":249,"height":217},{"@type":"BreadcrumbList","@id":"https:\/\/etfinveste.pt\/analise24_heal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/etfinveste.pt\/"},{"@type":"ListItem","position":2,"name":"iShares Healthcare Innovation UCITS ETF \u2013 HEAL"}]},{"@type":"WebSite","@id":"https:\/\/etfinveste.pt\/#website","url":"https:\/\/etfinveste.pt\/","name":"ETFinveste","description":"","publisher":{"@id":"https:\/\/etfinveste.pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/etfinveste.pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/etfinveste.pt\/#organization","name":"ETFinveste","url":"https:\/\/etfinveste.pt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/etfinveste.pt\/#\/schema\/logo\/image\/","url":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/02\/5b783120-b4fb-4def-8cb6-5eabeb8a8f6a_200x200.png","contentUrl":"https:\/\/etfinveste.pt\/wp-content\/uploads\/2021\/02\/5b783120-b4fb-4def-8cb6-5eabeb8a8f6a_200x200.png","width":200,"height":200,"caption":"ETFinveste"},"image":{"@id":"https:\/\/etfinveste.pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ETFinveste","https:\/\/x.com\/ETFinveste"]}]}},"_links":{"self":[{"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/pages\/6523"}],"collection":[{"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/comments?post=6523"}],"version-history":[{"count":99,"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/pages\/6523\/revisions"}],"predecessor-version":[{"id":6646,"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/pages\/6523\/revisions\/6646"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/media\/6555"}],"wp:attachment":[{"href":"https:\/\/etfinveste.pt\/wp-json\/wp\/v2\/media?parent=6523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}